S

AN FRANCISCO — At a J.P. Morgan Healthcare Conference that’s been dominated by talk of the hurdles that women face in the industry, GlaxoSmithKline’s (GSK) Emma Walmsley, a rare female CEO of a big pharmaceutical company, got a timely question.

How do you think about cultivating diversity in GSK’s leadership?

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

X